Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapivirine Vaginal Ring Open-Label Extension (DREAM)
NCT02862171Phase 3Completed
- Sponsor
- International Partnership for Microbicides
- Start
- Jul 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dapivirine in human immunodeficiency virus infection (HIV), sponsored by International Partnership for Microbicides. Started Jul 2016; status: completed.
02
Drugs
dapivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02862171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862171.